Three patients carried somatic pathogenic variants in the CTNNB1 gene [9,13], which have already been described in ACTs [2], while four patients exhibited marked IC2-LoM on tumor DNA [9,14,15]. The gene discussed is CTNNB1; the disease is neoplasm.